Zimmer Biomet Holdings (ZBH) Other Non-Current Assets (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Other Non-Current Assets of $1.1 billion for Q1 2026, little changed year-over-year from $1.1 billion in Q1 2025, and down 2.94% quarter-over-quarter from $1.1 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.39% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (changed 0.39% YoY), while the FY2025 annual figure was $1.1 billion, changed 0.44% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.2 billion in Q2 2024, with the low at $987.4 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $1.1 billion (2025), against an average of $1.1 billion.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 1838.17% in 2022, then fell 16.9% in 2025.
- Zimmer Biomet Holdings' Other Non-Current Assets stood at $1.1 billion in 2022, then gained by 2.66% to $1.2 billion in 2023, then slipped by 4.91% to $1.1 billion in 2024, then increased by 0.44% to $1.1 billion in 2025, then fell by 2.94% to $1.1 billion in 2026.
- Business Quant data shows ZBH's Other Non-Current Assets at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Bn |
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.07 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.21 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 987.40 Mn |
| Dec 31, 2021 | 57.90 Mn |
| Sep 30, 2021 | 1.01 Bn |